November 4, 2016
Lartruvo-soft tissue sarcoma drug to sell in U.S.
FDA granted accelerated approval to Lartruvo (olaratumab) injection, in combination with doxorubicin, for the treatment of adult patients…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
November 4, 2016
Cardinal Health approves a regular quarterly dividend
Cardinal Health has announced on Thursday that the board of directors approved a regular quarterly dividend…
November 4, 2016
Gelesis weight loss capsules increase fullnes, study shows
Gelesis, focused on developing first-in-class products to safely induce weight loss and improve glycaemic control, has presented new data for its second product candidate, Gelesis200
November 3, 2016
Horizon’s urea cycle disorder drug to sell in Canada
Horizon Pharma has announced that Ravicti (glycerol phenylbutyrate) Oral Liquid is now available in Canada through its affiliate….
November 3, 2016
Alkermes awards $1M to support people affected by mental health
Alkermes, a global biopharmaceutical company developing medicines for the treatment of central nervous system…
November 3, 2016
LeoPharma and Morphosys join forces to fight skin diseases
LEO Pharma and MorphoSys AG have entered into a strategic alliance for the discovery and development of therapeutic antibodies for the treatment…
November 3, 2016
ValiRx’s new cancer drug progresses into the clinic
ValiRx’s new cancer drug VAL401 progresses into the clinic
November 3, 2016
Positive outcome of Mereo’s phase 1 study of acute exacerbations of COPD drug
Mereo reports positive outcome of its phase 1 study of acute exacerbations of COPD drug
November 3, 2016
Strides, Mylan settle Regulatory and General Claims on Agila transaction, Strides gets $30M
Strides and Mylan have agree to settle Regulatory and General Claims on Agila transaction.
November 2, 2016
Eli Lilly, Incyte’s rheumatoid arthritis drug studies show positive effect
Eli Lilly and Company and Incyte Corporation have announced on Wednesday that new data from RA-BEACON – a pivotal phase 3 study…